Skip to content
Search

Latest Stories

Community Mental Health survey reveals only 39% felt supported by NHS mental health services

Community Mental Health survey reveals only 39% felt supported by NHS mental health services
According to the community mental health survey, 42 per cent felt unsupported during critical waiting periods

The NHS Long Term Plan and NHS Mental Health implementation plan requires the National Health Services to treat mental health with the same urgency as physical health.

However, the recently published Community Mental Health Survey 2023 by the Care Quality Commission (CQC) has shed light on the substandard quality of care experienced by individuals in the community across different aspects of care provision.


With feedback from 14,770 respondents including responses from 16- and 17-year-olds, who received treatment for mental health conditions between April 1 and May 31, 2023, the survey outcomes highlight deficiencies in quality of care, crisis intervention, support during waiting periods, care planning, and involvement in decision-making processes.

While some positive findings emerged, such as high levels of satisfaction with medication reviews and privacy during therapy sessions, significant shortcomings remain apparent.

Alarmingly, less than half of respondents (39 per cent) felt they received the necessary assistance during their last interaction with mental health services, and only 50 per cent believed they were allocated sufficient time to discuss their needs and treatment.

Of particular concern were experiences during waiting periods, with nearly 44 per cent reporting deteriorating mental health while awaiting treatment.

Furthermore, 42 per cent of respondents felt unsupported between assessment and initial treatment appointments, with 40 per cent expressing dissatisfaction with waiting times.

For the first time, the survey highlighted respondents using Child and Adolescent Mental Health Services (CAMHS), revealing subpar experiences across several domains.

Moreover, discussions on medication side effects and discontinuation were less frequent.

The survey also identified critical areas for improvement, particularly in crisis care and support during waiting periods.

Sir Julian Hartley, chief executive of NHS Providers, expressed deep concern over the regulator's findings, emphasising the pressing need to address the challenges faced by these vital services amidst soaring demand.

"NHS trusts will be very concerned by the regulator's findings and are determined to do everything they can to give people the care they need in the face of record demand," he said.

"It's clear that under-pressure services have more to do to ensure that people get timely, high-quality care and support but to aid trusts' efforts we need broader, cross-government action to address the gap between demand for mental health care and trusts' ability to provide it." he added further.

More For You

national prescribing service for pharmacists

Sadik Al-Hassan MP

Sadik-Al-Hassan: National pharmacy prescribing service “entirely possible”

A national prescribing service for pharmacists could in theory be developed in the next two-three years according to Sadik-Al-Hassan MP.

Speaking at an event organised by PharmaTech in parliament on Wednesday, Hassan said community pharmacists had the skillset to prescribe but a national service would be “limited” by what they are currently allowed to do.

Keep ReadingShow less
First daily pill for endometriosis to be available on NHS

Instead of travelling to clinics for injections, endometriosis patients can take a daily tablet at home

Getty Images

New endometriosis pill approved for NHS use, but only few patients will benefit

The National Institute for Health and Care Excellence (NICE) has approved a new pill for the treatment of endometriosis, providing hope for thousands of women affected by the debilitating condition.

The pill, called relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo), is the first long-term daily pill approved for use in the UK to treat endometriosis, and it is expected to help about 1,000 patients every year.

Keep ReadingShow less
​RPS urges its members and fellows to vote in favour of Royal College for “a stronger, louder voice”

The Special Resolution Vote will remain open until 5 p.m. on Thursday, 24 March 2025.

Getty Images

Royal College voting begins: A historic moment in the profession’s evolution

Becoming a royal college will ensure pharmacy profession gains the recognition and authority it deserves, says RPS president Professor Claire Anderson.

Starting today (13), members and fellows of the Royal Pharmaceutical Society (RPS) will begin voting on the proposed changes to its Royal Charter, marking the beginning of a historic shift toward becoming the Royal College of Pharmacy.

Keep ReadingShow less
GPs to play crucial role in transforming Wales’ health service

Jeremy Miles

(Photo credit: www.gov.wales )

Strengthening GPs’ role key to transforming healthcare - Jeremy Miles

Welsh health secretary Jeremy Miles has recognised the need to transform health services and bring healthcare closer to home.

Speaking at the recent Welsh Local Medical Committees Conference, he emphasised that strengthening the role of GPs would be crucial in improving patient healthcare and tackling NHS waiting lists.

Keep ReadingShow less